Details of the Drug Reposition

General Information of This Drug (ID: DMNZA4L)

Drug Name
Griffithsin   DMNZA4L
Synonyms GRFT
Therapeutic Class
Antiviral Agents
Drug Type
Protein/peptide drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Human immunodeficiency virus infection DISRNAI4 1C62 Phase 1 [1]
------------------------------------------------------------------------------------
1 Preclinical Indication(s)
Indication Name Indication ID ICD-11 Status REF
Severe acute respiratory syndrome (SARS) DISYW14W 1D65 Preclinical [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02875119) Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women
2 Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov. 2016 May;15(5):327-47.